111 related articles for article (PubMed ID: 1803028)
1. Comparison of a serotonin antagonist, opioid antagonist, and TRH analog for the acute treatment of experimental spinal trauma.
Puniak MA; Freeman GM; Agresta CA; Van Newkirk L; Barone CA; Salzman SK
J Neurotrauma; 1991; 8(3):193-203. PubMed ID: 1803028
[TBL] [Abstract][Full Text] [Related]
2. The serotonin antagonist mianserin improves functional recovery following experimental spinal trauma.
Salzman SK; Puniak MA; Liu ZJ; Maitland-Heriot RP; Freeman GM; Agresta CA
Ann Neurol; 1991 Oct; 30(4):533-41. PubMed ID: 1789683
[TBL] [Abstract][Full Text] [Related]
3. A comparison of YM-14673, U-50488H, and nalmefene after spinal cord injury in the rat.
Behrmann DL; Bresnahan JC; Beattie MS
Exp Neurol; 1993 Feb; 119(2):258-67. PubMed ID: 8432363
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single and combination drug treatment strategies in experimental brain trauma.
Faden AI
J Neurotrauma; 1993; 10(2):91-100. PubMed ID: 8411221
[TBL] [Abstract][Full Text] [Related]
5. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673.
Behrmann DL; Bresnahan JC; Beattie MS
Exp Neurol; 1994 Mar; 126(1):61-75. PubMed ID: 8157127
[TBL] [Abstract][Full Text] [Related]
6. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies.
Faden AI
Brain Res; 1989 May; 486(2):228-35. PubMed ID: 2499400
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat.
McIntosh TK; Fernyak S; Hayes RL; Faden AI
J Neurotrauma; 1993; 10(4):373-84. PubMed ID: 8145261
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of TRH analogs in rat spinal cord injury.
Faden AI; Sacksen I; Noble LJ
Brain Res; 1988 May; 448(2):287-93. PubMed ID: 3132308
[TBL] [Abstract][Full Text] [Related]
9. Treatment of experimental spinal cord injury with TRH, naloxone, and dexamethasone.
Arias MJ
Surg Neurol; 1987 Nov; 28(5):335-8. PubMed ID: 3116691
[TBL] [Abstract][Full Text] [Related]
10. Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.
Faden AI; Sacksen I; Noble LJ
J Pharmacol Exp Ther; 1988 May; 245(2):742-8. PubMed ID: 3367315
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
[TBL] [Abstract][Full Text] [Related]
12. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury.
Faden AI
Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771
[TBL] [Abstract][Full Text] [Related]
13. Histopathology of experimental spinal cord trauma. Comparison of treatment with TRH, naloxone, and dexamethasone.
Akdemir H; Paşaoğlu A; Oztürk F; Selçuklu A; Koç K; Kurtsoy A
Res Exp Med (Berl); 1992; 192(3):177-83. PubMed ID: 1636062
[TBL] [Abstract][Full Text] [Related]
14. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
Salzman SK; Kelly G; Chavin J; Wang L; Puniak MA; Agresta CA; Azim S
J Pharmacol Exp Ther; 1994 Apr; 269(1):322-8. PubMed ID: 8169839
[TBL] [Abstract][Full Text] [Related]
16. Opiate-receptor antagonists, thyrotropin-releasing hormone (TRH), and TRH analogs in the treatment of spinal cord injury.
Faden AI
Cent Nerv Syst Trauma; 1987; 4(4):217-26. PubMed ID: 3128405
[No Abstract] [Full Text] [Related]
17. Treatment of experimental spinal trauma with thyrotropin-releasing hormone: central serotonergic and vascular mechanisms of action.
Salzman SK; Hirofugi E; Knight PB; Llados-Eckman C; Beckman AL; Winokur A
Cent Nerv Syst Trauma; 1987; 4(3):181-96. PubMed ID: 3127060
[TBL] [Abstract][Full Text] [Related]
18. [Spinal cord evoked potential in experimental spinal cord injury--the changes in spinal cord evoked potential following impact injury, and effect of mannitol administration on acute experimental spinal cord injury].
Isu T
Hokkaido Igaku Zasshi; 1990 Mar; 65(2):142-51. PubMed ID: 2114347
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute spinal cord injuries: comparison of thyrotropin-releasing hormone and nimodipine.
Ceylan S; Ilbay K; Baykal S; Ceylan S; Sener U; Ozmenoğlu M; Kalelioğlu M; Aktürk F; Komsuoğlu SS; Ozoran A
Res Exp Med (Berl); 1992; 192(1):23-33. PubMed ID: 1570411
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: dose-window and time-window effects.
Gaviria M; Privat A; d'Arbigny P; Kamenka JM; Haton H; Ohanna F
J Neurotrauma; 2000 Jan; 17(1):19-30. PubMed ID: 10674755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
